FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 253 filers reported holding FATE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,302,183 | -60.9% | 2,029,332 | -12.3% | 0.00% | -50.0% |
| Q2 2023 | $11,013,835 | +13.3% | 2,313,831 | +35.6% | 0.00% | 0.0% |
| Q1 2023 | $9,724,610 | -35.1% | 1,706,072 | +14.9% | 0.00% | -33.3% |
| Q4 2022 | $14,985,032 | +51.1% | 1,485,137 | +235.7% | 0.00% | +50.0% |
| Q3 2022 | $9,915,000 | +1.1% | 442,439 | +11.8% | 0.00% | 0.0% |
| Q2 2022 | $9,804,000 | -45.4% | 395,629 | -14.6% | 0.00% | -33.3% |
| Q1 2022 | $17,964,000 | +31.3% | 463,322 | +98.2% | 0.00% | 0.0% |
| Q4 2021 | $13,678,000 | +2.4% | 233,757 | +3.7% | 0.00% | +50.0% |
| Q3 2021 | $13,361,000 | -79.1% | 225,432 | -69.4% | 0.00% | -85.7% |
| Q2 2021 | $63,980,000 | -17.7% | 737,184 | -21.9% | 0.01% | -26.3% |
| Q1 2021 | $77,780,000 | -27.3% | 943,349 | -19.8% | 0.02% | -32.1% |
| Q4 2020 | $107,010,000 | +1.0% | 1,176,840 | -55.6% | 0.03% | -3.4% |
| Q3 2020 | $105,935,000 | -7.4% | 2,650,370 | -20.5% | 0.03% | -27.5% |
| Q2 2020 | $114,371,000 | +122.9% | 3,333,477 | +44.3% | 0.04% | +73.9% |
| Q1 2020 | $51,312,000 | +194.7% | 2,310,328 | +159.7% | 0.02% | +228.6% |
| Q4 2019 | $17,410,000 | +90.6% | 889,617 | +51.2% | 0.01% | +75.0% |
| Q3 2019 | $9,135,000 | +1807.1% | 588,225 | +2392.5% | 0.00% | – |
| Q2 2019 | $479,000 | -97.1% | 23,600 | -97.4% | 0.00% | -100.0% |
| Q1 2019 | $16,240,000 | -0.8% | 924,289 | -27.6% | 0.01% | -11.1% |
| Q4 2018 | $16,379,000 | +24.8% | 1,276,642 | +58.5% | 0.01% | +50.0% |
| Q3 2018 | $13,123,000 | +826.1% | 805,546 | +544.5% | 0.01% | +500.0% |
| Q2 2018 | $1,417,000 | +2149.2% | 124,980 | +1105.2% | 0.00% | – |
| Q4 2017 | $63,000 | 0.0% | 10,370 | -24.6% | 0.00% | – |
| Q1 2017 | $63,000 | +28.6% | 13,746 | -5.0% | 0.00% | – |
| Q4 2015 | $49,000 | – | 14,464 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $51,820,000 | 67.63% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $307,258,000 | 39.62% |
| Darwin Global Management, Ltd. | 952,847 | $86,642,000 | 24.18% |
| Redmile Group, LLC | 12,629,737 | $1,148,422,000 | 13.91% |
| DAFNA Capital Management LLC | 334,360 | $30,403,000 | 9.05% |
| Casdin Capital, LLC | 3,050,000 | $277,337,000 | 8.22% |
| Grosvenor Holdings, L.L.C. | 1,459,517 | $132,714,000 | 7.23% |
| Copernicus Capital Management, LLC | 3,240 | $295,000 | 4.60% |
| Eversept Partners, LP | 399,499 | $36,326,444 | 4.26% |
| Ally Bridge Group (NY) LLC | 260,000 | $23,642,000 | 4.05% |